目前，检验结果智慧解读系统已在规范化建成的146家各级医疗机构实验室实现全覆盖，不仅显著提升了解读准确 率，更帮助基层实现了"检验不出社区、报告即时可读"。一位来自蓝田县的患者感慨道："以前为了一张报告往返 奔波，如今在家门口抽血，手机上立刻就能看明白，心里特别踏实。" 西安医检始终秉持"以技术赋能医疗，以数据守护健康"的建设理念。未来，西安医检将进一步拓展AI在疾病预 测、无人机送样及智慧医疗城市大脑融合等领域的应用，尤其在应急场景下，无人机快速送检较传统运输可节省 近三分之二时间，可极大缩短危急患者的等待窗口；助力构建从"诊断"到"预防"、从"单点服务"到"全域协同"的 智慧医疗新生态，让科技真正服务于民、惠及于民。 西安区域医学检验中心 曾经，一份检验报告满是难以读懂的数据与符号，如今只需扫码，AI 即时为您解读。检验结果智慧解读系统深度 融合了4000余个基于医学知识的解读模板，覆盖常见检验项目，并结合200余个经真实数据训练的AI分析模型， 实现对复杂指标的精准判断，不仅能清晰解释每一项指标，还能智能分析多份报告、提示异常关联指标，甚至预 测健康风险。自检验结果智慧解读系统上线以来，已累计完成报告解 ...

Group 1 - The 15th National Games and the 12th National Paralympic Games will be held in the Guangdong-Hong Kong-Macao Greater Bay Area, serving as a significant platform to showcase urban development, technological innovation, and regional cooperation [1][3] - The event is expected to enhance the overall image of the Greater Bay Area and deepen regional integration, with a focus on promoting public health management from "having" to "optimizing" [1] - The demand for event operations, health monitoring, and scientific fitness will drive breakthroughs and commercialization in AI medical big data, wearable devices, and smart healthcare [1] Group 2 - The integration of "sports + healthcare" is anticipated to break industry boundaries, attracting high-end resources to the Greater Bay Area and creating a "platform for events, stage for industries" effect [1] - The 15th National Games is viewed as an important opportunity to promote high-quality development in sports and public fitness [3] - A special column titled "15th Games 365 Days 365 People" will be launched to highlight stories and expectations surrounding the event, aiming to increase public awareness and engagement [3]

截至6月30日，迈瑞医疗股东户数9.16万，较上期减少0.68%；人均流通股13241股，较上期增加0.69%。 2025年1月-6月，迈瑞医疗实现营业收入167.43亿元，同比减少18.45%；归母净利润50.69亿元，同比减 少32.96%。 分红方面，迈瑞医疗A股上市后累计派现336.99亿元。近三年，累计派现233.88亿元。 机构持仓方面，截止2025年6月30日，迈瑞医疗十大流通股东中，香港中央结算有限公司位居第三大流 通股东，持股1.31亿股，相比上期减少302.52万股。易方达创业板ETF（159915）位居第五大流通股 东，持股1365.26万股，相比上期减少3.01万股。华宝中证医疗ETF（512170）位居第六大流通股东，持 股1101.24万股，相比上期增加88.93万股。华泰柏瑞沪深300ETF（510300）位居第七大流通股东，持股 1081.65万股，相比上期增加88.31万股。易方达沪深300医药ETF（512010）位居第八大流通股东，持股 996.89万股，相比上期减少75.63万股。景顺长城新兴成长混合A（260108）位居第九大流通股东，持股 800.00万股，持股数量 ...

Core Viewpoint - Lepu Medical experienced a stock price decline of 2.08% on September 26, with a trading price of 17.42 yuan per share and a total market capitalization of 32.76 billion yuan [1] Financial Performance - Lepu Medical's revenue for the first half of 2025 was 3.369 billion yuan, a year-on-year decrease of 0.43%, while the net profit attributable to shareholders was 691 million yuan, down 0.91% year-on-year [2] - The company has cumulatively distributed 4.957 billion yuan in dividends since its A-share listing, with 2.058 billion yuan distributed in the last three years [3] Stock Market Activity - The stock price of Lepu Medical has increased by 57.68% year-to-date, but it has seen a decline of 4.96% in the last five trading days and 7.59% over the past 20 days [1] - The company has appeared on the "Dragon and Tiger List" once this year, with a net buy of 29.5585 million yuan on June 4 [1] Shareholder Structure - As of June 30, 2025, Lepu Medical had 100,100 shareholders, an increase of 6.18% from the previous period, with an average of 16,152 circulating shares per shareholder, down 5.82% [2] - Major shareholders include Huabao Zhongzheng Medical ETF and E Fund Growth Enterprise ETF, with changes in their holdings noted [3]

9月26日，英科医疗盘中上涨2.01%，截至10:22，报37.54元/股，成交1.71亿元，换手率1.00%，总市值 245.81亿元。 资金流向方面，主力资金净流出745.45万元，特大单买入412.42万元，占比2.41%，卖出658.84万元，占 比3.86%；大单买入2395.34万元，占比14.02%，卖出2894.37万元，占比16.94%。 英科医疗今年以来股价涨49.08%，近5个交易日涨5.27%，近20日涨2.21%，近60日涨46.64%。 资料显示，英科医疗科技股份有限公司位于山东省淄博市临淄区齐鲁化学工业园清田路18号,香港湾仔 皇后大道东248号阳光中心40楼，成立日期2009年7月20日，上市日期2017年7月21日，公司主营业务涉 及涵盖个人防护、康复护理、其他产品三大板块。主营业务收入构成为：个人防护类91.47%，康复护 理类4.75%，其他产品3.77%。 英科医疗所属申万行业为：医药生物-医疗器械-医疗耗材。所属概念板块包括：医用耗材、智慧医疗、 抗原检测、医疗器械、跨境电商等。 截至6月30日，英科医疗股东户数6.00万，较上期减少2.96%；人均流通股7825股， ...

英科医疗今年以来股价涨46.94%，近5个交易日涨3.99%，近20日跌1.73%，近60日涨45.15%。 资料显示，英科医疗科技股份有限公司位于山东省淄博市临淄区齐鲁化学工业园清田路18号,香港湾仔 皇后大道东248号阳光中心40楼，成立日期2009年7月20日，上市日期2017年7月21日，公司主营业务涉 及涵盖个人防护、康复护理、其他产品三大板块。主营业务收入构成为：个人防护类91.47%，康复护 理类4.75%，其他产品3.77%。 9月25日，英科医疗盘中下跌2.01%，截至13:50，报37.00元/股，成交4.68亿元，换手率2.67%，总市值 242.27亿元。 资金流向方面，主力资金净流出1567.62万元，特大单买入1279.07万元，占比2.73%，卖出2541.32万 元，占比5.43%；大单买入8113.51万元，占比17.34%，卖出8418.87万元，占比17.99%。 截至6月30日，英科医疗股东户数6.00万，较上期减少2.96%；人均流通股7825股，较上期增加3.07%。 2025年1月-6月，英科医疗实现营业收入49.13亿元，同比增长8.90%；归母净利润7.10亿 ...

资金流向方面，主力资金净流入821.61万元，大单买入2255.90万元，占比20.87%，卖出1434.29万元， 占比13.27%。 麦迪科技今年以来股价涨45.62%，近5个交易日涨1.15%，近20日涨0.34%，近60日跌6.96%。 今年以来麦迪科技已经8次登上龙虎榜，最近一次登上龙虎榜为3月10日，当日龙虎榜净买入3115.92万 元；买入总计1.15亿元 ，占总成交额比8.31%；卖出总计8361.32万元 ，占总成交额比6.06%。 9月25日，麦迪科技盘中上涨2.18%，截至13:41，报14.97元/股，成交1.08亿元，换手率2.38%，总市值 45.85亿元。 资料显示，苏州麦迪斯顿医疗科技股份有限公司位于江苏省苏州工业园区归家巷222号，成立日期2009 年8月14日，上市日期2016年12月8日，公司主营业务涉及提供临床医疗管理信息系统(CIS)系列应用软 件和临床信息化的整体解决方案。主营业务收入构成为：自制软件40.39%，运维服务31.55%，医疗服 务21.12%，整体解决方案4.60%，外购软硬件1.95%，其他0.40%。 责任编辑：小浪快报 截至6月30日，麦迪科技 ...

9月25日，迈瑞医疗盘中上涨2.01%，截至11:20，报238.60元/股，成交12.90亿元，换手率0.45%，总市 值2892.89亿元。 截至6月30日，迈瑞医疗股东户数9.16万，较上期减少0.68%；人均流通股13241股，较上期增加0.69%。 2025年1月-6月，迈瑞医疗实现营业收入167.43亿元，同比减少18.45%；归母净利润50.69亿元，同比减 少32.96%。 分红方面，迈瑞医疗A股上市后累计派现336.99亿元。近三年，累计派现233.88亿元。 机构持仓方面，截止2025年6月30日，迈瑞医疗十大流通股东中，香港中央结算有限公司位居第三大流 通股东，持股1.31亿股，相比上期减少302.52万股。易方达创业板ETF（159915）位居第五大流通股 东，持股1365.26万股，相比上期减少3.01万股。华宝中证医疗ETF（512170）位居第六大流通股东，持 股1101.24万股，相比上期增加88.93万股。华泰柏瑞沪深300ETF（510300）位居第七大流通股东，持股 1081.65万股，相比上期增加88.31万股。易方达沪深300医药ETF（512010）位居第八大流通股 ...

Core Viewpoint - Anbiping's stock price has shown significant volatility in 2023, with a year-to-date increase of 57.23%, but recent declines in the short term raise concerns about its performance [2]. Financial Performance - As of June 30, 2025, Anbiping reported a revenue of 159 million yuan, a year-on-year decrease of 30.11%, and a net profit attributable to shareholders of -12.5 million yuan, a decline of 176.38% [2]. - The company has distributed a total of 87.8 million yuan in dividends since its A-share listing, with 36.5 million yuan distributed over the past three years [3]. Stock Market Activity - On September 25, Anbiping's stock rose by 2.04% to 27.06 yuan per share, with a trading volume of 16.5 million yuan and a turnover rate of 0.66%, resulting in a total market capitalization of 2.532 billion yuan [1]. - The stock has experienced a net outflow of 844,700 yuan in principal funds, with large orders accounting for 18.17% of total purchases and 23.29% of total sales [1]. Shareholder Structure - As of June 30, 2025, Anbiping had 9,221 shareholders, a decrease of 10.55% from the previous period, with an average of 10,147 circulating shares per shareholder, an increase of 11.80% [2]. - Among the top ten circulating shareholders, Changcheng Consumption Value Mixed A (200006) is the eighth largest, holding 850,000 shares as a new shareholder [3]. Business Overview - Anbiping, established on July 6, 2005, and listed on August 20, 2020, is based in Guangzhou, Guangdong Province, and specializes in the research, production, and sales of in vitro diagnostic reagents and instruments [2]. - The company's revenue composition includes 79.72% from self-produced products, 13.11% from purchased products, 5.90% from service income, and 1.27% from other sources [2].

Core Insights - Digital healthcare is rapidly integrating into daily life, showcasing advanced technologies and interactive experiences at the Global Digital Trade Expo [1] Group 1: Digital Healthcare Innovations - The fourth-generation flexible exoskeleton robot developed in China outperforms similar products in endurance and adaptability, marking a significant advancement in rehabilitation equipment [2] - The brain-controlled exoskeleton allows patients to control a mechanical arm using muscle signals, achieving a response time of less than 200 milliseconds, demonstrating international leadership in technology [2] - The fully automated, unmanned cell experiment assembly line by Deshi Bio is a groundbreaking system that automates traditional laboratory processes, enhancing efficiency and accuracy [3] Group 2: AI and Traditional Medicine - An AI medical assistant translates complex health reports into understandable language within three seconds, currently utilized in over 500 medical institutions, interpreting more than 200,000 reports daily [4] - The AI-based traditional Chinese medicine consultation experience combines tongue image scanning and pulse diagnosis to generate health reports in 30 seconds, revitalizing traditional practices with technology [4] - Smart elderly care devices, including companion robots and monitoring systems, significantly reduce caregiver workload and enhance emotional support for the elderly [4] Group 3: Exhibition Highlights - The digital healthcare exhibition features major international companies like Medtronic and GE Healthcare, alongside innovative local enterprises, showcasing cutting-edge medical technology and intelligent health services [4] - Attendees can engage in immersive experiences with AI-assisted diagnostics and remote surgeries, enhancing their understanding of future healthcare environments [5] - The expo will host ten professional forums featuring industry experts and academicians discussing the latest trends in digital healthcare, providing valuable insights to participants [6]